Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 6,552 shares at $65.58 ($430K) on 2024-01-17, disclosed to the SEC on 2024-01-18.
Scheduled sale ($430k) by Chief People Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.58 | 3,276 | $215K | 50.0% |
| 2 | $65.58 | 3,276 | $215K | 50.0% |
| Total | $65.58 avg | 6,552 | $430K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $37K | — | Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-31 | $139K | — | Filing → |